RET and medullary thyroid gland carcinoma: Approximately 25% of MTC cases are ‘hereditary’ and associated with pathogenic germline variants in RET (REarranged during Transfection) protooncogene which cause MEN2 syndrome [4], including 5–7% of patients with apparently ‘sporadic’ disease in whom the mutation arises de novo [5].